Establish South Korea as a Hub of Innovation to Create Best & First Class ADCs, Bispecifics, T-Cell Engagers, and Protein Degraders that Deliver More Targeted, Efficacious & Safer Therapies for Patients
South Korea is fast becoming the epicenter of targeted therapeutics innovation, particularly on ADCs, bispecifics, T-Cell Engagers and TPDs converge.
To meet the growing demand for safer, more effective drugs with broader therapeutic windows that can improve on standard of care treatments and meet an unmet medical need, the World Targeted Therapeutics Summit South Korea brings together three of the hottest modalities under one roof to create unparalleled opportunities for idea exchange, collaboration, and networking.
Taking place as three co-located events with the flagship 5th World ADC South Korea, and the brand new World Bispecific & T-Cell Engager Summit South Korea and the World TPD & Induced Proximity Summit South Korea, this is your opportunity to gain comprehensive coverage of the fastest-growing R&D areas in Korea.
With an audience ranging from C-level execs and VP/Directors, join over 400 leading experts to drive innovation, differentiate your pipeline and accelerate precision-driven cancer care.
Key Topics
Attending Companies Include